Washington, Oct 3: US agency the Food and Drug Administration (FDA) has approved a new knee-surgery device developed by researchers at the University of Missouri-Columbia which helps in repairing meniscus tears for use in humans.
The device, called BioDuct Meniscal Fixation Device, helps repair meniscus tears, which were previously defined as irreparable.
The meniscus, a padding tissue that provides shock absorption and joint stability in the knee, is essential for normal knee function.